Ol deep tablet 5/40 milligrams
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
MFDS item code 201404993 · Approved 2014.10.28 · Insurance code 640902810
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with either amlodipine or olmesartan medoxomil. By reliably managing blood pressure, it reduces the risk of cardiovascular complications and improves the overall health of the patient. Therefore, it plays an important role in the treatment of essential hypertension and contributes to the patient's quality of life.
Take 1 tablet once daily with water, with or without food. It is recommended, if possible, to take this medicine at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or olmesartan medoxomil) be adjusted. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily. Administration of this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended for patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil for patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics. This medicine must not be administered to patients with severe hepatic impairment. (See section 2, Patients who must not be administered this medicine, under Precautions for Use.) ∘Older adults: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in older adults.
∘Children: Safety and efficacy have not been established in pediatric patients under 18 years of age.
This medication should not be taken during the second and third trimesters of pregnancy as it can cause serious harm to the fetus and newborn. It should not be used in patients with allergies to any of the active ingredients or similar drugs, pregnant or breastfeeding women, patients with severe liver disease, aortic stenosis, cholestasis, or those on kidney dialysis. In patients with low blood volume or salt deficiency, hypotension may occur, so careful monitoring is necessary during initial administration. Those with aortic stenosis should be particularly cautious, as sudden vasodilation may occur, leading to hypotension. Patients with coronary artery disease or heart failure should use this medication with caution, and patients with impaired kidney function should also use it carefully. Possible side effects include dizziness, headache, hypotension, swelling, dyspepsia, rash, etc., and any unusual symptoms should be discussed with a healthcare provider. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and a doctor should be consulted. Breastfeeding mothers should note that this medication may pass into breast milk, so they may need to discontinue breastfeeding or stop taking the medication. Children under 18 years of age are not recommended to use this medication as its safety and efficacy have not been established. Older adults may experience reduced liver and kidney function, so it is recommended to start with a lower dose and administer it carefully. Overdose of this medication can lead to severe hypotension and vascular dilation, causing increased heart rate; therefore, if symptoms occur, it is essential to notify healthcare personnel immediately. This medication should be stored away from direct sunlight and moisture in a sealed container and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve its effectiveness.
Light yellow round film-coated tablet
28 tablets/box [(14 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.